Rani Therapeutics Hldgs Stock (NASDAQ: RANI) stock price, news, charts, stock research, profile.
Open | $6.600 |
Close | - |
Volume / Avg. | 64.736K / 128.374K |
Day Range | 6.160 - 6.600 |
52 Wk Range | 1.820 - 8.750 |
Market Cap | $173.221M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 14.62% |
Days to Cover | 23.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rani Therapeutics Hldgs (NASDAQ: RANI) through any online brokerage.
Other companies in Rani Therapeutics Hldgs’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Alimera Sciences (NASDAQ:ALIM), Telomir Pharmaceuticals (NASDAQ:TELO) and Trevi Therapeutics (NASDAQ:TRVI).
The latest price target for Rani Therapeutics Hldgs (NASDAQ: RANI) was reported by Canaccord Genuity on Wednesday, March 27, 2024. The analyst firm set a price target for 9.00 expecting RANI to rise to within 12 months (a possible 39.75% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $6.44 last updated Today at April 30, 2024 at 2:37 PM EDT.
There are no upcoming dividends for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.